Novel opioid peptides endomorphin-1 and endomorphin-2 are present in mammalian immune tissues

被引:41
|
作者
Jessop, DS
Major, GN
Coventry, TL
Kaye, SJ
Fulford, AJ
Harbuz, MS
De Bree, FM
机构
[1] Univ Bristol, Div Med, Bristol BS2 8HW, Avon, England
[2] Univ Newcastle, Sch Med, Med Mol Biol Grp, Newcastle, NSW 2308, Australia
基金
英国惠康基金;
关键词
opioids; endomorphins; spleen; thymus; rat; human;
D O I
10.1016/S0165-5728(99)00216-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Endomorphin (EM)-1 and EM-2 are opioid tetrapeptides, reported within the central nervous system, which have very high specificity and affinity for the mu-opioid receptor. We have used newly developed and well-characterised radioimmunoassays (RIAs) in combination with reversed-phase high-performance liquid chromatography (HPLC) to detect EM-1 and EM-2 immunoreactivity (ir) in rat immune tissues. Endomorphins were detectable in extracts of rat spleen (total EM-1-ir/spleen: 440 +/- 73 pg, mean +/- SEM, a=group of eight rats; EM-2-ir: 150 +/- 12 pg) and thymus (EM-1-ir: 152 +/- 18 pg, mean +/- SEM n=8; EM-2-ir: 156+/-28 pg). EM-2-ir was detectable in extracts of human spleen (338+/-196 pg/g tissue, n=3). Multiple peaks of EM-1-ir and EM-2-ir were observed in rat spleen and thymus extracts, and multiple peaks of EM-2-ir were observed in extracts of human spleen, following reversed-phase HPLC and RIAs. This is the first report of endomorphin immunoreactivity in tissues of the rat and human immune systems. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 50 条
  • [11] Endomorphin-induced motivational effect: Differential mechanism of endomorphin-1 and endomorphin-2
    Narita, M
    Ozaki, S
    Suzuki, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 89 (03): : 224 - 228
  • [12] Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice
    Soignier, RD
    Vaccarino, AL
    Brennan, AM
    Kastin, AJ
    Zadina, JE
    LIFE SCIENCES, 2000, 67 (08) : 907 - 912
  • [13] Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse
    Tseng, LF
    Narita, M
    Suganuma, C
    Mizoguchi, H
    Ohsawa, M
    Nagase, H
    Kampine, JP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 292 (02): : 576 - 583
  • [14] Activation and internalization of the μ-opioid receptor by the newly discovered endogenous agonists, endomorphin-1 and endomorphin-2
    McConalogue, K
    Grady, EF
    Minnis, J
    Balestra, B
    Tonini, M
    Brecha, NC
    Bunnett, NW
    Sternini, C
    NEUROSCIENCE, 1999, 90 (03) : 1051 - 1059
  • [15] Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice
    Fichna, Jakub
    Janecka, Anna
    Piestrzeniewicz, Mariola
    Costentin, Jean
    do Rego, Jean-Claude
    NEUROPSYCHOPHARMACOLOGY, 2007, 32 (04) : 813 - 821
  • [16] Antidepressant-Like Effect of Endomorphin-1 and Endomorphin-2 in Mice
    Jakub Fichna
    Anna Janecka
    Mariola Piestrzeniewicz
    Jean Costentin
    Jean-Claude do Rego
    Neuropsychopharmacology, 2007, 32 : 813 - 821
  • [17] Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice
    Fichna, J.
    Piestrzeniewicz, M.
    Costentin, J.
    do-Rego, J. -C
    Janecka, A.
    FEBS JOURNAL, 2006, 273 : 330 - 331
  • [18] Search of the human proteome for endomorphin-1 and endomorphin-2 precursor proteins
    Terskiy, Alexandra
    Wannemacher, Kenneth M.
    Yadav, Prem N.
    Tsai, Michael
    Tian, Bin
    Howells, Richard D.
    LIFE SCIENCES, 2007, 81 (23-24) : 1593 - 1601
  • [19] Identification of Endomorphin-1 and Endomorphin-2 Binding Sites in Human μ-Opioid Receptor by Antisense Oligonucleotide Strategy
    Fichna, Jakub
    Gach, Katarzyna
    Perlikowska, Renata
    Poels, Jeroen
    Broeck, Jozef Vanden
    Szemraj, Janusz
    Janecka, Anna
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 72 (06) : 507 - 512
  • [20] Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse
    Ohsawa, M
    Mizoguchi, H
    Narita, M
    Nagase, H
    Kampine, JP
    Tseng, LF
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (02): : 592 - 597